| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serpin family protein binding | 1.76e-06 | 2 | 27 | 2 | GO:0097655 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity involved in apoptotic process | 7.87e-06 | 29 | 27 | 3 | GO:0008656 | |
| GeneOntologyMolecularFunction | cysteine-type carboxypeptidase activity | 1.05e-05 | 4 | 27 | 2 | GO:0016807 | |
| GeneOntologyMolecularFunction | peptidase activator activity involved in apoptotic process | 1.07e-05 | 32 | 27 | 3 | GO:0016505 | |
| GeneOntologyMolecularFunction | kininogen binding | 1.76e-05 | 5 | 27 | 2 | GO:0030984 | |
| GeneOntologyMolecularFunction | fibronectin binding | 1.80e-05 | 38 | 27 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.40e-05 | 51 | 27 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 5.22e-05 | 54 | 27 | 3 | GO:0043028 | |
| GeneOntologyMolecularFunction | cysteine-type exopeptidase activity | 7.87e-05 | 10 | 27 | 2 | GO:0070004 | |
| GeneOntologyMolecularFunction | peptidase activator activity | 1.14e-04 | 70 | 27 | 3 | GO:0016504 | |
| GeneOntologyMolecularFunction | collagen binding | 1.75e-04 | 81 | 27 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 2.02e-04 | 656 | 27 | 6 | GO:0008047 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 2.09e-04 | 86 | 27 | 3 | GO:0004197 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 4.15e-04 | 1418 | 27 | 8 | GO:0030234 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 5.26e-04 | 507 | 27 | 5 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 5.26e-04 | 507 | 27 | 5 | GO:0060589 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 1.54e-03 | 43 | 27 | 2 | GO:0004177 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 1.83e-03 | 47 | 27 | 2 | GO:0051539 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 1.99e-03 | 49 | 27 | 2 | GO:0004180 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.16e-03 | 192 | 27 | 3 | GO:0008234 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 4.91e-03 | 257 | 27 | 3 | GO:0061134 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 4.96e-03 | 78 | 27 | 2 | GO:0051536 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 5.28e-03 | 1233 | 27 | 6 | GO:0140677 | |
| GeneOntologyMolecularFunction | histone binding | 5.34e-03 | 265 | 27 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | metal cluster binding | 5.60e-03 | 83 | 27 | 2 | GO:0051540 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.16e-03 | 279 | 27 | 3 | GO:0005096 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 8.35e-03 | 102 | 27 | 2 | GO:0005249 | |
| GeneOntologyMolecularFunction | peptide binding | 8.82e-03 | 318 | 27 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 9.65e-03 | 110 | 27 | 2 | GO:0008238 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.67e-06 | 32 | 27 | 3 | GO:0019886 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 1.39e-05 | 36 | 27 | 3 | GO:0002495 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.64e-05 | 38 | 27 | 3 | GO:0002504 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 3.07e-05 | 139 | 27 | 4 | GO:0019882 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 3.33e-05 | 48 | 27 | 3 | GO:0002478 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 3.74e-05 | 499 | 27 | 6 | GO:0051345 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 4.49e-05 | 53 | 27 | 3 | GO:0030574 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 5.88e-05 | 58 | 27 | 3 | GO:0019884 | |
| GeneOntologyBiologicalProcess | catagen | 5.91e-05 | 9 | 27 | 2 | GO:0042637 | |
| GeneOntologyBiologicalProcess | elastin catabolic process | 7.38e-05 | 10 | 27 | 2 | GO:0060309 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.32e-04 | 76 | 27 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | elastin metabolic process | 1.49e-04 | 14 | 27 | 2 | GO:0051541 | |
| GeneOntologyBiologicalProcess | hair cycle phase | 4.10e-04 | 23 | 27 | 2 | GO:0044851 | |
| GeneOntologyBiologicalProcess | thyroid hormone generation | 4.86e-04 | 25 | 27 | 2 | GO:0006590 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 5.26e-04 | 26 | 27 | 2 | GO:0060088 | |
| GeneOntologyBiologicalProcess | hair follicle maturation | 6.56e-04 | 29 | 27 | 2 | GO:0048820 | |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte proliferation | 6.56e-04 | 29 | 27 | 2 | GO:0010839 | |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 7.50e-04 | 31 | 27 | 2 | GO:0002093 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 7.50e-04 | 31 | 27 | 2 | GO:0043373 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | 8.03e-04 | 878 | 27 | 6 | GO:0051336 | |
| GeneOntologyBiologicalProcess | decidualization | 8.50e-04 | 33 | 27 | 2 | GO:0046697 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 8.50e-04 | 33 | 27 | 2 | GO:0002363 | |
| GeneOntologyBiologicalProcess | thyroid hormone metabolic process | 9.02e-04 | 34 | 27 | 2 | GO:0042403 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 9.33e-04 | 148 | 27 | 3 | GO:0032963 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 9.56e-04 | 35 | 27 | 2 | GO:0043369 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 1.25e-03 | 40 | 27 | 2 | GO:0060117 | |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 1.25e-03 | 40 | 27 | 2 | GO:0031069 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 1.31e-03 | 641 | 27 | 5 | GO:1901615 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 1.31e-03 | 41 | 27 | 2 | GO:0060441 | |
| GeneOntologyBiologicalProcess | glycoprotein catabolic process | 1.31e-03 | 41 | 27 | 2 | GO:0006516 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 1.38e-03 | 42 | 27 | 2 | GO:0002360 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic signaling pathway | 1.49e-03 | 174 | 27 | 3 | GO:2001235 | |
| GeneOntologyBiologicalProcess | maternal placenta development | 1.51e-03 | 44 | 27 | 2 | GO:0001893 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 1.65e-03 | 46 | 27 | 2 | GO:0048730 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 1.81e-03 | 1028 | 27 | 6 | GO:0043085 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | 1.97e-03 | 1430 | 27 | 7 | GO:0044093 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidase activity | 1.97e-03 | 192 | 27 | 3 | GO:0010952 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 2.18e-03 | 53 | 27 | 2 | GO:0060122 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 2.18e-03 | 53 | 27 | 2 | GO:0043368 | |
| GeneOntologyBiologicalProcess | biological phase | 2.18e-03 | 53 | 27 | 2 | GO:0044848 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 2.43e-03 | 56 | 27 | 2 | GO:2001259 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 2.43e-03 | 56 | 27 | 2 | GO:0010837 | |
| GeneOntologyCellularComponent | endolysosome lumen | 1.60e-05 | 5 | 27 | 2 | GO:0036021 | |
| GeneOntologyCellularComponent | lysosomal lumen | 2.69e-04 | 98 | 27 | 3 | GO:0043202 | |
| GeneOntologyCellularComponent | endolysosome | 6.83e-04 | 30 | 27 | 2 | GO:0036019 | |
| GeneOntologyCellularComponent | endosome lumen | 1.40e-03 | 43 | 27 | 2 | GO:0031904 | |
| GeneOntologyCellularComponent | vacuolar lumen | 1.53e-03 | 178 | 27 | 3 | GO:0005775 | |
| HumanPheno | Expressive language delay | 6.78e-05 | 56 | 8 | 3 | HP:0002474 | |
| HumanPheno | Language delay | 6.78e-05 | 56 | 8 | 3 | HP:0002336 | |
| HumanPheno | Severe expressive language delay | 1.41e-04 | 12 | 8 | 2 | HP:0006863 | |
| MousePheno | periodontal ligament necrosis | 2.59e-06 | 2 | 23 | 2 | MP:0030515 | |
| MousePheno | abnormal lymph node medullary sinus morphology | 2.59e-06 | 2 | 23 | 2 | MP:0011222 | |
| MousePheno | dilated lymph node medullary sinus | 2.59e-06 | 2 | 23 | 2 | MP:0011223 | |
| MousePheno | insulitis | 9.87e-06 | 26 | 23 | 3 | MP:0004031 | |
| MousePheno | folliculitis | 2.58e-05 | 5 | 23 | 2 | MP:0000376 | |
| MousePheno | dental pulp necrosis | 2.58e-05 | 5 | 23 | 2 | MP:0013251 | |
| MousePheno | hair follicle outer root sheath hyperplasia | 2.58e-05 | 5 | 23 | 2 | MP:0010688 | |
| MousePheno | enlarged thymus cortex | 2.58e-05 | 5 | 23 | 2 | MP:0013593 | |
| MousePheno | salivary gland inflammation | 3.16e-05 | 38 | 23 | 3 | MP:0001870 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 5.28e-05 | 45 | 23 | 3 | MP:0004804 | |
| MousePheno | mitral valve regurgitation | 5.41e-05 | 7 | 23 | 2 | MP:0006045 | |
| MousePheno | abnormal R wave | 5.41e-05 | 7 | 23 | 2 | MP:0011919 | |
| MousePheno | dilated piliary canal | 7.21e-05 | 8 | 23 | 2 | MP:0030571 | |
| MousePheno | sparse vibrissae | 7.21e-05 | 8 | 23 | 2 | MP:0001283 | |
| MousePheno | abnormal hair cycle catagen phase | 9.26e-05 | 9 | 23 | 2 | MP:0008859 | |
| MousePheno | abnormal T wave | 9.26e-05 | 9 | 23 | 2 | MP:0010505 | |
| MousePheno | increased heart left atrium size | 9.26e-05 | 9 | 23 | 2 | MP:0008726 | |
| MousePheno | hypergranulosis | 9.26e-05 | 9 | 23 | 2 | MP:0009600 | |
| MousePheno | focal dorsal hair loss | 9.26e-05 | 9 | 23 | 2 | MP:0010202 | |
| MousePheno | abnormal salivary gland physiology | 1.13e-04 | 58 | 23 | 3 | MP:0005310 | |
| MousePheno | abnormal lymph node medulla morphology | 1.16e-04 | 10 | 23 | 2 | MP:0002348 | |
| MousePheno | abnormal susceptibility to autoimmune disorder | 1.20e-04 | 307 | 23 | 5 | MP:0002425 | |
| MousePheno | abnormal merocrine gland physiology | 1.25e-04 | 60 | 23 | 3 | MP:0013557 | |
| MousePheno | abnormal piliary canal morphology | 1.69e-04 | 12 | 23 | 2 | MP:0030570 | |
| MousePheno | thick epidermis stratum granulosum | 1.69e-04 | 12 | 23 | 2 | MP:0009599 | |
| MousePheno | lymph node inflammation | 1.69e-04 | 12 | 23 | 2 | MP:0003865 | |
| MousePheno | abnormal dental pulp morphology | 1.69e-04 | 12 | 23 | 2 | MP:0013250 | |
| MousePheno | abnormal CD4-positive T cell differentiation | 1.90e-04 | 69 | 23 | 3 | MP:0008076 | |
| MousePheno | decreased susceptibility to autoimmune disorder | 1.94e-04 | 180 | 23 | 4 | MP:0005351 | |
| MousePheno | aortic valve regurgitation | 2.00e-04 | 13 | 23 | 2 | MP:0006047 | |
| MousePheno | atrioventricular valve regurgitation | 2.00e-04 | 13 | 23 | 2 | MP:0006046 | |
| MousePheno | abnormal periodontal ligament morphology | 2.00e-04 | 13 | 23 | 2 | MP:0003668 | |
| MousePheno | increased circulating glucose level | 2.12e-04 | 553 | 23 | 6 | MP:0005559 | |
| MousePheno | pancreas inflammation | 2.15e-04 | 72 | 23 | 3 | MP:0001869 | |
| MousePheno | abnormal vibrissa morphology | 2.16e-04 | 185 | 23 | 4 | MP:0002098 | |
| MousePheno | excessive scratching | 2.68e-04 | 15 | 23 | 2 | MP:0001412 | |
| MousePheno | absent vibrissae | 3.05e-04 | 81 | 23 | 3 | MP:0001284 | |
| MousePheno | abnormal hair follicle outer root sheath morphology | 3.06e-04 | 16 | 23 | 2 | MP:0010684 | |
| MousePheno | abnormal dental pulp cavity morphology | 3.06e-04 | 16 | 23 | 2 | MP:0002819 | |
| MousePheno | orthokeratosis | 3.06e-04 | 16 | 23 | 2 | MP:0009675 | |
| MousePheno | short hair | 3.06e-04 | 16 | 23 | 2 | MP:0000417 | |
| MousePheno | abnormal thymus corticomedullary boundary morphology | 3.47e-04 | 17 | 23 | 2 | MP:0009543 | |
| MousePheno | greasy coat | 3.47e-04 | 17 | 23 | 2 | MP:0003849 | |
| MousePheno | semilunar valve regurgitation | 3.90e-04 | 18 | 23 | 2 | MP:0006049 | |
| MousePheno | autoimmune response | 4.02e-04 | 398 | 23 | 5 | MP:0001844 | |
| MousePheno | abnormal self tolerance | 4.11e-04 | 400 | 23 | 5 | MP:0005005 | |
| MousePheno | abnormal immune tolerance | 4.30e-04 | 404 | 23 | 5 | MP:0005000 | |
| MousePheno | abnormal external auditory canal morphology | 4.35e-04 | 19 | 23 | 2 | MP:0006033 | |
| MousePheno | abnormal hair follicle orientation | 4.35e-04 | 19 | 23 | 2 | MP:0000383 | |
| MousePheno | delayed hair appearance | 4.35e-04 | 19 | 23 | 2 | MP:0000422 | |
| MousePheno | short vibrissae | 4.83e-04 | 20 | 23 | 2 | MP:0001282 | |
| MousePheno | underdeveloped hair follicles | 5.34e-04 | 21 | 23 | 2 | MP:0000382 | |
| MousePheno | thick dermal layer | 5.86e-04 | 22 | 23 | 2 | MP:0001245 | |
| MousePheno | abnormal heart left atrium morphology | 5.86e-04 | 22 | 23 | 2 | MP:0003923 | |
| MousePheno | enlarged sebaceous gland | 6.42e-04 | 23 | 23 | 2 | MP:0000652 | |
| MousePheno | hyperglycemia | 6.54e-04 | 105 | 23 | 3 | MP:0001559 | |
| MousePheno | shiny skin | 6.99e-04 | 24 | 23 | 2 | MP:0001196 | |
| MousePheno | rough coat | 6.99e-04 | 24 | 23 | 2 | MP:0010179 | |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 6.99e-04 | 24 | 23 | 2 | MP:0010841 | |
| MousePheno | cardiac valve regurgitation | 8.22e-04 | 26 | 23 | 2 | MP:0009384 | |
| MousePheno | increased keratinocyte proliferation | 8.86e-04 | 27 | 23 | 2 | MP:0009583 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 1.10e-03 | 30 | 23 | 2 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 1.10e-03 | 30 | 23 | 2 | MP:0010840 | |
| MousePheno | abnormal heart valve physiology | 1.10e-03 | 30 | 23 | 2 | MP:0011926 | |
| MousePheno | lymph node hyperplasia | 1.33e-03 | 33 | 23 | 2 | MP:0008102 | |
| MousePheno | abnormal periodontium morphology | 1.41e-03 | 34 | 23 | 2 | MP:0030131 | |
| MousePheno | increased central memory CD8 positive, alpha-beta T cell number | 1.49e-03 | 35 | 23 | 2 | MP:0010847 | |
| MousePheno | amyloidosis | 1.49e-03 | 35 | 23 | 2 | MP:0000604 | |
| MousePheno | abnormal amyloid deposition | 1.49e-03 | 35 | 23 | 2 | MP:0021152 | |
| MousePheno | granulomatous inflammation | 1.58e-03 | 36 | 23 | 2 | MP:0002500 | |
| MousePheno | abnormal CD8-positive, alpha-beta T cell differentiation | 1.67e-03 | 37 | 23 | 2 | MP:0008080 | |
| MousePheno | abnormal epidermis stratum basale morphology | 1.67e-03 | 37 | 23 | 2 | MP:0001231 | |
| MousePheno | abnormal brain interneuron morphology | 1.67e-03 | 37 | 23 | 2 | MP:0004101 | |
| MousePheno | abnormal cochlear hair cell physiology | 1.94e-03 | 40 | 23 | 2 | MP:0004432 | |
| MousePheno | abnormal keratinocyte proliferation | 2.04e-03 | 41 | 23 | 2 | MP:0009582 | |
| MousePheno | increased effector memory CD4-positive, alpha-beta T cell number | 2.04e-03 | 41 | 23 | 2 | MP:0010844 | |
| MousePheno | abnormal central memory CD8-positive, alpha-beta T cell number | 2.14e-03 | 42 | 23 | 2 | MP:0012772 | |
| MousePheno | abnormal central memory CD8 positive, alpha-beta T cell morphology | 2.14e-03 | 42 | 23 | 2 | MP:0010846 | |
| MousePheno | acanthosis | 2.24e-03 | 43 | 23 | 2 | MP:0001874 | |
| MousePheno | focal hair loss | 2.24e-03 | 43 | 23 | 2 | MP:0000418 | |
| MousePheno | abnormal circulating glucose level | 2.29e-03 | 1188 | 23 | 7 | MP:0000188 | |
| MousePheno | decreased long bone epiphyseal plate size | 2.35e-03 | 44 | 23 | 2 | MP:0006396 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 2.46e-03 | 45 | 23 | 2 | MP:0009611 | |
| MousePheno | increased heart atrium size | 2.56e-03 | 46 | 23 | 2 | MP:0008725 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell number | 2.79e-03 | 48 | 23 | 2 | MP:0012770 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell morphology | 2.79e-03 | 48 | 23 | 2 | MP:0010843 | |
| MousePheno | hearing/vestibular/ear phenotype | 2.82e-03 | 905 | 23 | 6 | MP:0005377 | |
| MousePheno | abnormal hair cell physiology | 2.91e-03 | 49 | 23 | 2 | MP:0003879 | |
| MousePheno | abnormal heart echocardiography feature | 2.91e-03 | 49 | 23 | 2 | MP:0011925 | |
| MousePheno | abnormal ligament morphology | 2.91e-03 | 49 | 23 | 2 | MP:0005504 | |
| MousePheno | cardiac interstitial fibrosis | 3.02e-03 | 50 | 23 | 2 | MP:0005608 | |
| MousePheno | abnormal lymph node cortex morphology | 3.02e-03 | 50 | 23 | 2 | MP:0002343 | |
| MousePheno | decreased thyroxine level | 3.14e-03 | 51 | 23 | 2 | MP:0005471 | |
| MousePheno | thick skin | 3.27e-03 | 52 | 23 | 2 | MP:0001200 | |
| MousePheno | abnormal thymus cortex morphology | 3.27e-03 | 52 | 23 | 2 | MP:0002371 | |
| Domain | Inhibitor_I29 | 9.39e-08 | 7 | 27 | 3 | PF08246 | |
| Domain | Prot_inhib_I29 | 9.39e-08 | 7 | 27 | 3 | IPR013201 | |
| Domain | Inhibitor_I29 | 9.39e-08 | 7 | 27 | 3 | SM00848 | |
| Domain | Pept_asp_AS | 3.21e-07 | 10 | 27 | 3 | IPR025661 | |
| Domain | Pept_his_AS | 4.41e-07 | 11 | 27 | 3 | IPR025660 | |
| Domain | Pept_C1 | 7.63e-07 | 13 | 27 | 3 | SM00645 | |
| Domain | Peptidase_C1A_C | 7.63e-07 | 13 | 27 | 3 | IPR000668 | |
| Domain | Peptidase_C1 | 7.63e-07 | 13 | 27 | 3 | PF00112 | |
| Domain | Peptidase_C1A | 7.63e-07 | 13 | 27 | 3 | IPR013128 | |
| Domain | THIOL_PROTEASE_CYS | 6.85e-06 | 26 | 27 | 3 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 7.70e-06 | 27 | 27 | 3 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 7.70e-06 | 27 | 27 | 3 | PS00639 | |
| Domain | Pept_cys_AS | 8.62e-06 | 28 | 27 | 3 | IPR000169 | |
| Domain | TIL | 1.32e-04 | 12 | 27 | 2 | PF01826 | |
| Domain | C8 | 1.32e-04 | 12 | 27 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.55e-04 | 13 | 27 | 2 | IPR014853 | |
| Domain | C8 | 1.55e-04 | 13 | 27 | 2 | SM00832 | |
| Domain | TIL_dom | 1.81e-04 | 14 | 27 | 2 | IPR002919 | |
| Domain | VWFD | 2.39e-04 | 16 | 27 | 2 | PS51233 | |
| Domain | VWD | 2.39e-04 | 16 | 27 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.39e-04 | 16 | 27 | 2 | IPR001846 | |
| Domain | VWD | 2.39e-04 | 16 | 27 | 2 | PF00094 | |
| Domain | VWC_out | 3.39e-04 | 19 | 27 | 2 | SM00215 | |
| Domain | RCC1 | 3.76e-04 | 20 | 27 | 2 | PF00415 | |
| Domain | RCC1_3 | 4.16e-04 | 21 | 27 | 2 | PS50012 | |
| Domain | RCC1_1 | 4.16e-04 | 21 | 27 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.16e-04 | 21 | 27 | 2 | PS00626 | |
| Domain | Reg_chr_condens | 4.57e-04 | 22 | 27 | 2 | IPR000408 | |
| Domain | - | 4.57e-04 | 22 | 27 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 5.00e-04 | 23 | 27 | 2 | IPR009091 | |
| Domain | VWC | 1.37e-03 | 38 | 27 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.37e-03 | 38 | 27 | 2 | PS50184 | |
| Domain | VWF_dom | 1.67e-03 | 42 | 27 | 2 | IPR001007 | |
| Domain | SAM | 7.14e-03 | 88 | 27 | 2 | SM00454 | |
| Domain | SAM_DOMAIN | 8.27e-03 | 95 | 27 | 2 | PS50105 | |
| Domain | SAM | 8.61e-03 | 97 | 27 | 2 | IPR001660 | |
| Domain | ZF_RING_2 | 8.86e-03 | 298 | 27 | 3 | PS50089 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.67e-07 | 11 | 21 | 3 | M525 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 8.07e-07 | 13 | 21 | 3 | M593 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 8.07e-07 | 13 | 21 | 3 | MM14659 | |
| Pathway | KEGG_LYSOSOME | 2.76e-05 | 121 | 21 | 4 | M11266 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.34e-05 | 50 | 21 | 3 | MM14796 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES | 5.89e-05 | 8 | 21 | 2 | M27796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.70e-05 | 61 | 21 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.87e-04 | 76 | 21 | 3 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.08e-04 | 90 | 21 | 3 | M631 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 4.98e-04 | 106 | 21 | 3 | M518 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.16e-04 | 114 | 21 | 3 | MM14571 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 6.48e-04 | 116 | 21 | 3 | MM14855 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 8.24e-04 | 126 | 21 | 3 | M705 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.12e-03 | 140 | 21 | 3 | M587 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.44e-03 | 38 | 21 | 2 | MM14611 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.50e-03 | 155 | 21 | 3 | MM14665 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.95e-03 | 170 | 21 | 3 | M7494 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 2.18e-03 | 381 | 21 | 4 | M1066 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 4.28e-03 | 66 | 21 | 2 | MM15875 | |
| Pubmed | A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. | 4.67e-10 | 3 | 28 | 3 | 11884425 | |
| Pubmed | Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice. | 4.67e-10 | 3 | 28 | 3 | 16895486 | |
| Pubmed | Spatially and temporally defined lysosomal leakage facilitates mitotic chromosome segregation. | 1.87e-09 | 4 | 28 | 3 | 31932607 | |
| Pubmed | Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis. | 1.87e-09 | 4 | 28 | 3 | 26075905 | |
| Pubmed | Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. | 1.87e-09 | 4 | 28 | 3 | 19640986 | |
| Pubmed | Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. | 1.87e-09 | 4 | 28 | 3 | 19664906 | |
| Pubmed | Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. | 1.87e-09 | 4 | 28 | 3 | 16508006 | |
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 19939935 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 21251246 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 10395917 | ||
| Pubmed | Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. | 4.67e-09 | 5 | 28 | 3 | 16481467 | |
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 33786919 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 12186844 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 15905550 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 15308097 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 10748235 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 18591414 | ||
| Pubmed | Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P. | 9.33e-09 | 6 | 28 | 3 | 10760593 | |
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 20080943 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 24145449 | ||
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 27477282 | ||
| Pubmed | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. | 2.61e-08 | 8 | 28 | 3 | 22916010 | |
| Pubmed | Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis. | 3.91e-08 | 9 | 28 | 3 | 29909986 | |
| Pubmed | 5.59e-08 | 10 | 28 | 3 | 28087651 | ||
| Pubmed | 1.02e-07 | 12 | 28 | 3 | 9096102 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11022031 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23585893 | ||
| Pubmed | Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. | 6.25e-07 | 2 | 28 | 2 | 9545226 | |
| Pubmed | Cathepsin L gene expression and promoter activation in rodent granulosa cells. | 6.25e-07 | 2 | 28 | 2 | 14563703 | |
| Pubmed | Cathepsin L is crucial for the development of early experimental diabetic nephropathy. | 6.25e-07 | 2 | 28 | 2 | 27575559 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19801522 | ||
| Pubmed | Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. | 6.25e-07 | 2 | 28 | 2 | 11972068 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 36735789 | ||
| Pubmed | Cathepsin L plays an active role in involution of the mouse mammary gland. | 6.25e-07 | 2 | 28 | 2 | 12815617 | |
| Pubmed | Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury. | 6.25e-07 | 2 | 28 | 2 | 28332696 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20877570 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19900452 | ||
| Pubmed | Impaired turnover of autophagolysosomes in cathepsin L deficiency. | 6.25e-07 | 2 | 28 | 2 | 20536383 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16621972 | ||
| Pubmed | Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression. | 6.25e-07 | 2 | 28 | 2 | 25957406 | |
| Pubmed | Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis. | 6.25e-07 | 2 | 28 | 2 | 33540247 | |
| Pubmed | Expression of cathepsins V and S in thymic epithelial tumors. | 6.25e-07 | 2 | 28 | 2 | 27771373 | |
| Pubmed | The protease cathepsin L regulates Th17 cell differentiation. | 6.25e-07 | 2 | 28 | 2 | 26343333 | |
| Pubmed | Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. | 6.25e-07 | 2 | 28 | 2 | 16636100 | |
| Pubmed | Cloning, genomic organization, and chromosomal localization of human cathepsin L. | 6.25e-07 | 2 | 28 | 2 | 8419312 | |
| Pubmed | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation. | 6.25e-07 | 2 | 28 | 2 | 31010818 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20338168 | ||
| Pubmed | Thymocyte expression of cathepsin L is essential for NKT cell development. | 6.25e-07 | 2 | 28 | 2 | 12368909 | |
| Pubmed | Cloning and characterization of a mouse cysteine proteinase. | 6.25e-07 | 2 | 28 | 2 | 3533924 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 1482371 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12163394 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20347002 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 27586811 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15154914 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23608608 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23912553 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12748383 | ||
| Pubmed | Developmental expression of cathepsin L and c-rasHa in the mouse placenta. | 6.25e-07 | 2 | 28 | 2 | 1751032 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29154036 | ||
| Pubmed | Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. | 6.25e-07 | 2 | 28 | 2 | 12163455 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31771567 | ||
| Pubmed | Cathepsin L Helps to Defend Mice from Infection with Influenza A. | 6.25e-07 | 2 | 28 | 2 | 27716790 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16393949 | ||
| Pubmed | Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization. | 6.25e-07 | 2 | 28 | 2 | 20304958 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11978977 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 2275556 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12054558 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11398968 | ||
| Pubmed | Cathepsin L is involved in proliferation and invasion of breast cancer cells. | 6.25e-07 | 2 | 28 | 2 | 26639231 | |
| Pubmed | A variant of pulmonary alveolar microlithiasis in nackt mice. | 6.25e-07 | 2 | 28 | 2 | 12014504 | |
| Pubmed | An alternate targeting pathway for procathepsin L in mouse fibroblasts. | 6.25e-07 | 2 | 28 | 2 | 11929604 | |
| Pubmed | Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis. | 6.25e-07 | 2 | 28 | 2 | 20023699 | |
| Pubmed | Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis. | 6.25e-07 | 2 | 28 | 2 | 23600672 | |
| Pubmed | Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis. | 6.25e-07 | 2 | 28 | 2 | 12533435 | |
| Pubmed | Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes. | 6.25e-07 | 2 | 28 | 2 | 12941783 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12000732 | ||
| Pubmed | Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells. | 6.25e-07 | 2 | 28 | 2 | 36206719 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15905545 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12466121 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 3689328 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10516062 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19096818 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11023992 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17671649 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 3755373 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21434350 | ||
| Pubmed | Alterations during positive selection in the thymus of nackt CD4-deficient mice. | 6.25e-07 | 2 | 28 | 2 | 11119260 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21972973 | ||
| Pubmed | Cell type-specific functions of the lysosomal protease cathepsin L in the heart. | 6.25e-07 | 2 | 28 | 2 | 17942402 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16705169 | ||
| Pubmed | Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. | 6.25e-07 | 2 | 28 | 2 | 18469859 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32457751 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15679121 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 2835398 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 2826441 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 38329128 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 8554545 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19589362 | ||
| Pubmed | Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. | 6.25e-07 | 2 | 28 | 2 | 16184198 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16079282 | ||
| Interaction | CST3 interactions | 7.66e-06 | 29 | 27 | 3 | int:CST3 | |
| Interaction | D2HGDH interactions | 4.07e-05 | 146 | 27 | 4 | int:D2HGDH | |
| Cytoband | 3p24.3 | 1.25e-04 | 27 | 28 | 2 | 3p24.3 | |
| Cytoband | 1p36.22 | 2.36e-04 | 37 | 28 | 2 | 1p36.22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p24 | 2.18e-03 | 113 | 28 | 2 | chr3p24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 8.08e-03 | 681 | 28 | 3 | chr1p36 | |
| GeneFamily | Cathepsins | 5.22e-07 | 15 | 20 | 3 | 470 | |
| GeneFamily | Sterile alpha motif domain containing | 4.20e-03 | 88 | 20 | 2 | 760 | |
| GeneFamily | Actins|Deafness associated genes | 6.84e-03 | 113 | 20 | 2 | 1152 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.15e-02 | 206 | 20 | 2 | 682 | |
| Coexpression | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS | 2.79e-06 | 26 | 28 | 3 | MM639 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 4.28e-06 | 103 | 28 | 4 | M39240 | |
| Coexpression | NADLER_OBESITY_UP | 5.00e-05 | 67 | 28 | 3 | MM1007 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 160 | 28 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 160 | 28 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.36e-06 | 186 | 28 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.52e-05 | 142 | 28 | 3 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.52e-05 | 142 | 28 | 3 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.52e-05 | 142 | 28 | 3 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 152 | 28 | 3 | 525d65c5c8e5580947367afdb1f6e68b49e9e5bb | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 162 | 28 | 3 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 174 | 28 | 3 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | de3245e1ee269e422de0308d0dd3623e4e9eb182 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | c41c11171dfb40e5ddea6bf97d9373eb03a2321b | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 180 | 28 | 3 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-04 | 181 | 28 | 3 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.14e-04 | 187 | 28 | 3 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|(2)_5-FU / Stress and Cell class | 2.21e-04 | 189 | 28 | 3 | 0f169b17bb26a812a5b0dcd6e29a3ca8415fd197 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.25e-04 | 190 | 28 | 3 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 193 | 28 | 3 | 2653f83bc0289abdb4270c176ebdc24242600f9a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-04 | 193 | 28 | 3 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.39e-04 | 194 | 28 | 3 | 4428b472c2042f88eae028b1770767512a515b75 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.39e-04 | 194 | 28 | 3 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 195 | 28 | 3 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.42e-04 | 195 | 28 | 3 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 195 | 28 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.42e-04 | 195 | 28 | 3 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 195 | 28 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | distal-Hematologic-Plasma-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.46e-04 | 196 | 28 | 3 | 8201aded3c7109fae5e6ca12bac2076acc7bf070 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.46e-04 | 196 | 28 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 2.46e-04 | 196 | 28 | 3 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | distal-1-Hematologic-Plasma|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.50e-04 | 197 | 28 | 3 | f5499bfa9dbc111f12563b7006bc45c2423ad0cd | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.50e-04 | 197 | 28 | 3 | 121ec3f6d978de2f6c2cc397f7327d2e5587ab8b | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 2.54e-04 | 198 | 28 | 3 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.57e-04 | 199 | 28 | 3 | df946601b295be5419c09befbfa73f4314eef116 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| Computational | Neighborhood of CDC16 | 6.86e-05 | 75 | 12 | 3 | MORF_CDC16 | |
| Computational | Neighborhood of PTPN11 | 2.03e-04 | 108 | 12 | 3 | MORF_PTPN11 | |
| Computational | Neighborhood of MAX | 5.22e-04 | 31 | 12 | 2 | GCM_MAX | |
| Drug | Z-Phe-Phe-CHN2 | 3.31e-06 | 24 | 28 | 3 | CID005486921 | |
| Drug | cimaterol | 5.96e-06 | 29 | 28 | 3 | CID000002755 | |
| Drug | Zfrn-mec | 6.61e-06 | 30 | 28 | 3 | CID000125187 | |
| Drug | E64A | 7.32e-06 | 31 | 28 | 3 | CID000173548 | |
| Drug | desmedipham | 7.32e-06 | 31 | 28 | 3 | CID000024743 | |
| Drug | benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide | 8.74e-06 | 4 | 28 | 2 | ctd:C021159 | |
| Drug | Zfa-fmk | 3.74e-05 | 53 | 28 | 3 | CID000122019 | |
| Drug | dicyclohexyl phthalate | 5.29e-05 | 836 | 28 | 7 | ctd:C036042 | |
| Drug | AC1NBIRU | 6.00e-05 | 62 | 28 | 3 | CID004468718 | |
| Drug | glycolaldehyde | 6.52e-05 | 10 | 28 | 2 | ctd:C010972 | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 1822_DN | |
| Drug | AC1NR9X9 | 9.55e-05 | 12 | 28 | 2 | CID000657093 | |
| Drug | Neot | 9.55e-05 | 12 | 28 | 2 | CID000410270 | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 7006_DN | |
| Drug | AC1NRA23 | 9.78e-05 | 73 | 28 | 3 | CID005287657 | |
| Drug | I-o-T | 1.52e-04 | 15 | 28 | 2 | CID000447122 | |
| Disease | otitis media (biomarker_via_orthology) | 1.17e-04 | 17 | 28 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 2.37e-04 | 24 | 28 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 3.23e-04 | 28 | 28 | 2 | DOID:7998 (biomarker_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 3.47e-04 | 29 | 28 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 3.72e-04 | 30 | 28 | 2 | EFO_0000341, EFO_0004351 | |
| Disease | pancreatitis (biomarker_via_orthology) | 6.30e-04 | 39 | 28 | 2 | DOID:4989 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 9.93e-04 | 49 | 28 | 2 | DOID:684 (implicated_via_orthology) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.08e-03 | 51 | 28 | 2 | cv:CN043650 | |
| Disease | Nonsyndromic genetic hearing loss | 2.37e-03 | 76 | 28 | 2 | cv:C5680182 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.62e-03 | 80 | 28 | 2 | DOID:12930 (implicated_via_orthology) | |
| Disease | Parkinson disease | 3.42e-03 | 321 | 28 | 3 | MONDO_0005180 | |
| Disease | cerebral amyloid deposition measurement | 3.67e-03 | 95 | 28 | 2 | EFO_0007707 | |
| Disease | hearing impairment | 3.90e-03 | 98 | 28 | 2 | C1384666 | |
| Disease | brain ischemia (biomarker_via_orthology) | 4.22e-03 | 102 | 28 | 2 | DOID:2316 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GACGLGAVGQAQGQQ | 756 | Q5SNV9 | |
| AAGGGGTGLQEQQMS | 901 | Q8WWN8 | |
| RPQGNQGCNGGFMAR | 171 | O60911 | |
| GGGGRGNTNTNECRM | 56 | Q96NX9 | |
| MGNCVSGQQQEGGVS | 491 | Q14699 | |
| QTLGAQMQGGFGCGN | 3821 | Q8NEZ4 | |
| QMQGGFGCGNQLPKT | 3826 | Q8NEZ4 | |
| NNSMGQCGQGNSTGP | 691 | Q15751 | |
| QNGFSGGVGALGIMN | 406 | Q9HB15 | |
| GQEGFGINEIGGNGM | 331 | Q7Z5P9 | |
| CGFMGGLQRNGSTGQ | 1691 | Q2PPJ7 | |
| MNVSGCPGAGNASQA | 1 | O43603 | |
| GGGGQNGQQAMSLAI | 326 | P17658 | |
| PNTGRANQQMGGGFF | 131 | Q9NZS9 | |
| MGNGGRSGLQQGKGN | 1 | Q9H2C2 | |
| GGQMTTSTGNQNLCG | 431 | A0A0U1RQI7 | |
| GNKGCNGGFMTTAFQ | 176 | P25774 | |
| MKGQGGAGGQFLSGQ | 666 | Q9NZ71 | |
| GGGGGGARSNLNMNA | 151 | Q9H7E2 | |
| NNQGSNMGGGMNFGA | 301 | Q13148 | |
| MIQGGDFSNQNGTGG | 81 | Q08752 | |
| QNGGFFRMNSGECLG | 136 | Q9UK23 | |
| GVNNKGQCGRDTGAM | 706 | O75592 | |
| GQCGRDTGAMNQGGK | 711 | O75592 | |
| QGQGGKCAMLAAQNN | 1261 | Q6P1J6 | |
| FIASQGMGNGCGRSN | 2261 | Q9H2D6 | |
| GPQGNEGCNGGLMDY | 171 | P07711 | |
| GLGGVMAQAGFNGGN | 201 | O75443 | |
| GQGRGQGQSVQMSGA | 681 | Q92609 | |
| GICGSCAMNINGGNT | 96 | P21912 |